Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The same type of situation came about in Germany with the banks, the. Hitler came about and showed them exactly how much power they had.
Anyway, they are basically stealing from the rest of the market. People with types of morals need taken out, lined up along a ditch and shot in the back of the head. Mass burial is too good for these scumbags.
Sometimes the cost to current shareholders is 5-10 times the cost of the loan.
The fact is, there are predatory sharks in the water that lend money for shares with the cost of said loan being 2-3 times the money borrowed at the expense of current shareholders when the hedge fund in question is done shorting the company they just lent money to.
Advaxis might be smarter to float a loan at this point and if need be do financing to pay the interest. JMO
The other half was subject to a frontal lobotomy gone bad......
Absolutely agree, no way for a small company like this without income to do anything about it either.
It is about the hedge funds, anyone with half a brain would know that.
Make no mistake, what hedge funds are allowed to do in the stock market will damage the integrity of the stock market for generations to come, even if something were done today about them today. The same thing happened with letting china fleece Americans for the last thirty years. The damage is irreversible or will take decades to fix.
There must also be some interest from Merck as well as every trial involving NEO now has Merck in combo to boot.
Actually Amgen was very interested, Advaxis dragging their feet and not bargaining in good faith from the start spoiled the relationship.
They already owned the shares the surrendered to cover.
CVI covered, there’s a difference.
Probably the hedge fund who shorted us before the last offering.
I would think that Ken would have been out of his mind to petition the FDA for an earlier look at results without an agreement with someone to partner after that was accomplished. JMO, plus it seemed as though someone got startled trying to get out of the way once the announcement was made that the hold was lifted.
I like the science still, haven’t sold any shares, however the management of this company has left a lot to be desired in the past.
Oops, sorry, that was meant for BLUE.
Good to see you again Blue!
Or Less than three years regardless, it should be about half done already.
Just a gut feeling but I think we have something coming soon. That was part of why they petitioned the FDA, an interested party wanted an earlier look.
That P3 news scared someone and they saw fit to cover using HFT to scare folks out of their shares.
Been watching this stock for over a decade and the activity this week makes me think a deal will be announced soon.
I would love to see ken throw some news out about a deal to destroy these MFers!
This drop in share price off of good news makes one wonder if a hedgie is pressuring the company to do another offering after shorting it at a higher SP.
So at what point does Advaxis ask the sec to look into the trading here?
Ken needs to monetize something so that these A-holes will take a break.
You know Ig, they are slowly stealing the company with this management team in place.
Well, it might turn out that they really are, ha ha! There’s got to be some reason that someone sees fit to trounce any news with a foot up the ass plus the slow steady decline regardless of how many shares they have out there.
Someone is trying to pound this little company into the dirt!
So it’s taken the hedgies HFT almost 4 million trades to subdue the SP today.
You would see stable disease in these patients with weakened immune systems before you see the A bomb go off.
Not even the same class of patients. The guys Advaxis is treating in combo with Keytruda have no options left.
Those Prostate results at dang good, just like the AXAL cervical results. All NEO trials have Keytruda running in a combo arm as well. Just a matter of time till Merck springs for the whole ball of wax.
Or some event in the near future caused him to want to line something up. The advisory board gig says he still has a lot of respect at Advaxis.
The science is still ahead of it’s time, just not as far as it used to be.
Yeah, management is the question, can they get their shit together?
Those Prostate results are phenomenal, Merck will either sign a deal for that one or buy the whole company.
Stable disease after three doses with epitope spreading is phenomenal and buy them the time for their bodies to Strengthen and eliminate the cancer. Stable disease = time for this vaccine to work its manic. That’s all that Keytruda helped with in the first gen vaccines was buying more time. Sounds like the neoantigen vaccines do that for themselves.
The combo Prostate data looks stellar. I wouldn’t doubt that the patients with stable disease in the NEO trial eventually are complete responders. Given enough runway with these sick patients, their bodies immune system will strengthen and eliminate their cancer.
They’ll take it to 2.50 before Advaxis feels compelled to open their mouths. Seems like it’s a game they have going with the hedgies......Advaxis won’t give news until after the take down which makes it easier to control.